{"nct_id":"NCT04697953","title":"Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)","status":"WITHDRAWN","status_verified_date":"2021-09","start_date":"2021-05-31","start_date_type":"ESTIMATED","primary_completion_date":"2021-06-21","primary_completion_date_type":"ESTIMATED","completion_date":"2025-05-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}